These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 18333357

  • 1. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L, Zdrenghea D, Pop D, Crăciun A, Rusu ML, Mocan T.
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [Abstract] [Full Text] [Related]

  • 2. Stroke mortality and the apoB/apoA-I ratio: results of the AMORIS prospective study.
    Walldius G, Aastveit AH, Jungner I.
    J Intern Med; 2006 Mar; 259(3):259-66. PubMed ID: 16476103
    [Abstract] [Full Text] [Related]

  • 3. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
    Sniderman AD, Jungner I, Holme I, Aastveit A, Walldius G.
    J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
    [Abstract] [Full Text] [Related]

  • 4. Lipoprotein(a) levels are increased in healthy young subjects with parental history of premature myocardial infarction.
    Gaeta G, Cuomo S, Capozzi G, Foglia MC, Barra S, Madrid A, Stornaiuolo V, Trevisan M.
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):492-6. PubMed ID: 17962002
    [Abstract] [Full Text] [Related]

  • 5. Childhood levels of serum apolipoproteins B and A-I predict carotid intima-media thickness and brachial endothelial function in adulthood: the cardiovascular risk in young Finns study.
    Juonala M, Viikari JS, Kähönen M, Solakivi T, Helenius H, Jula A, Marniemi J, Taittonen L, Laitinen T, Nikkari T, Raitakari OT.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):293-9. PubMed ID: 18634985
    [Abstract] [Full Text] [Related]

  • 6. The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy--a review of the evidence.
    Walldius G, Jungner I.
    J Intern Med; 2006 May 22; 259(5):493-519. PubMed ID: 16629855
    [Abstract] [Full Text] [Related]

  • 7. [Apolipoproteins are new and better risk indicators of myocardial infarction].
    Walldius G, Jungner I.
    Lakartidningen; 2004 Mar 25; 101(13):1188-94. PubMed ID: 15101244
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study.
    Meisinger C, Loewel H, Mraz W, Koenig W.
    Eur Heart J; 2005 Feb 25; 26(3):271-8. PubMed ID: 15618061
    [Abstract] [Full Text] [Related]

  • 9. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH, Rasmi Y, Rahimi-Pour A, Jafarzadeh M.
    Singapore Med J; 2009 Jun 25; 50(6):610-3. PubMed ID: 19551315
    [Abstract] [Full Text] [Related]

  • 10. [Decrease ApoB/ApoA-1 ratio and cardiovascular risk improvement: a tadalafil pleiotropic effect? Preliminary study on healthy volunteers].
    Roumeguère T, Zouaoui Boudjeltia K, Hauzeur C, Ramal A, Schulman C, Vanhaeverbeek M, Ducobu J, Wespes E.
    Prog Urol; 2008 Dec 25; 18(13):1087-91. PubMed ID: 19041816
    [Abstract] [Full Text] [Related]

  • 11. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
    Ray KK, Cannon CP, Cairns R, Morrow DA, Ridker PM, Braunwald E.
    Arterioscler Thromb Vasc Biol; 2009 Mar 25; 29(3):424-30. PubMed ID: 19122170
    [Abstract] [Full Text] [Related]

  • 12. High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study.
    Walldius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E.
    Lancet; 2001 Dec 15; 358(9298):2026-33. PubMed ID: 11755609
    [Abstract] [Full Text] [Related]

  • 13. Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B: the Copenhagen City Heart Study.
    Benn M, Nordestgaard BG, Jensen GB, Tybjaerg-Hansen A.
    Arterioscler Thromb Vasc Biol; 2007 Mar 15; 27(3):661-70. PubMed ID: 17170368
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein (a) and lipid and non-lipid risk factors in coronaries risk assessment.
    Agoşton-Coldea L, Rusu LD, Zdrenghea D, Rusu ML, Pop D, Crăciun A, Poanta L, Gatfossé M, Rosenstingl S, Mocan T.
    Rom J Intern Med; 2008 Mar 15; 46(2):137-44. PubMed ID: 19284085
    [Abstract] [Full Text] [Related]

  • 15. Relationships between lipoprotein components and risk of myocardial infarction: age, gender and short versus longer follow-up periods in the Apolipoprotein MOrtality RISk study (AMORIS).
    Holme I, Aastveit AH, Jungner I, Walldius G.
    J Intern Med; 2008 Jul 15; 264(1):30-8. PubMed ID: 18298486
    [Abstract] [Full Text] [Related]

  • 16. ApoB/ApoA-I ratio in young patients with ischemic cerebral stroke or peripheral arterial disease.
    Sabino AP, De Oliveira Sousa M, Moreira Lima L, Dias Ribeiro D, Sant'Ana Dusse LM, Das Graças Carvalho M, Fernandes AP.
    Transl Res; 2008 Sep 15; 152(3):113-8. PubMed ID: 18774540
    [Abstract] [Full Text] [Related]

  • 17. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
    Shai I, Rimm EB, Hankinson SE, Curhan G, Manson JE, Rifai N, Stampfer MJ, Ma J.
    Circulation; 2004 Nov 02; 110(18):2824-30. PubMed ID: 15492318
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia].
    Muchacka-Bianga M, Deja G, Jarosz-Chobot P, Małecka-Tendera E, Kalina M, Grychtoł M.
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006 Nov 02; 12(1):25-30. PubMed ID: 16704858
    [Abstract] [Full Text] [Related]

  • 19. Apolipoprotein A-I versus HDL cholesterol in the prediction of risk for myocardial infarction and stroke.
    Walldius G, Jungner I.
    Curr Opin Cardiol; 2007 Jul 02; 22(4):359-67. PubMed ID: 17556890
    [Abstract] [Full Text] [Related]

  • 20. Apolipoproteins as markers and managers of coronary risk.
    Chan DC, Watts GF.
    QJM; 2006 May 02; 99(5):277-87. PubMed ID: 16504986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.